Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Cerebral deposition of amyloid beta peptide is an early and critical feature of Alzheimer's disease and a frequent complication of Down syndrome. Additionally we are shipping beta-Site APP-Cleaving Enzyme 2 Kits (29) and beta-Site APP-Cleaving Enzyme 2 Proteins (14) and many more products for this protein.
Showing 10 out of 151 products:
Human Polyclonal BACE2 Primary Antibody for EIA, IHC (p) - ABIN499397
Hussain, Powell, Howlett, Tew, Meek, Chapman, Gloger, Murphy, Southan, Ryan, Smith, Simmons, Walsh, Dingwall, Christie: Identification of a novel aspartic protease (Asp 2) as beta-secretase. in Molecular and cellular neurosciences 2000
Show all 4 references for ABIN499397
Human Polyclonal BACE2 Primary Antibody for EIA, IHC (p) - ABIN499395
Vassar, Bennett, Babu-Khan, Kahn, Mendiaz, Denis, Teplow, Ross, Amarante, Loeloff, Luo, Fisher, Fuller, Edenson, Lile, Jarosinski, Biere, Curran, Burgess, Louis, Collins, Treanor, Rogers, Citron: Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. in Science (New York, N.Y.) 1999
Show all 4 references for ABIN499395
Human Polyclonal BACE2 Primary Antibody for EIA, WB - ABIN358600
Basi, Frigon, Barbour, Doan, Gordon, McConlogue, Sinha, Zeller: Antagonistic effects of beta-site amyloid precursor protein-cleaving enzymes 1 and 2 on beta-amyloid peptide production in cells. in The Journal of biological chemistry 2003
Show all 3 references for ABIN358600
Human Polyclonal BACE2 Primary Antibody for EIA, WB - ABIN492805
Sun, He, Song: BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006
Show all 3 references for ABIN492805
Human Polyclonal BACE2 Primary Antibody for EIA, WB - ABIN492803
Lahiri, Maloney, Ge: Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal cells. in Journal of molecular neuroscience : MN 2006
Show all 3 references for ABIN492803
Human Polyclonal BACE2 Primary Antibody for FACS, WB - ABIN390067
Shi, Tugusheva, Bruce, Lucka, Wu, Chen-Dodson, Price, Li, Xu, Huang, Sardana, Hazuda: Beta-secretase cleavage at amino acid residue 34 in the amyloid beta peptide is dependent upon gamma-secretase activity. in The Journal of biological chemistry 2003
Show all 2 references for ABIN390067
the behavior of the flap (show ALOX5AP Antibodies) tips during simulations is different between BACE1 (show BACE Antibodies) and BACE2. The BACE1 (show BACE Antibodies) active site cavity is more spacious as compared to that of BACE2. The analysis of 10S loop and 113S loop showed a similar trend to that of flaps, with the BACE1 (show BACE Antibodies) loops being more flexible and less stable than those of BACE2
RNA-seq evidence of biallelic expression of BACE2 and 10 neighboring genes in at least one primary human tissue tested indicates that the expression of BACE2 is uncoupled from the control of the maternally inherited 5mCpG imprints at the WRB (show WRB Antibodies) differentially methylated region (DMR (show WDR20 Antibodies)) in disomic controls or trisomy (Down syndrome) individuals.
Studies suggest that beta-Secretases BACE1 (show BACE Antibodies)/2 plays an important role in retinal homeostasis and that BACE (show BACE Antibodies) upregulation in response to stress is a protective measure.
Data suggest that the amino acid residues would be essential for selectivity of beta-amyloid precursor protein cleavage enzymes BACE1 (show BACE Antibodies) and BACE2 functions and could be sites for the design of selective inhibitors targeting either BACE1 (show BACE Antibodies) or BACE2.
Data identified two novel genome-wide significant associations: 2-h plasma glucose and HKDC1, and fasting C-peptide and BACE2.
BACE2 cle (show BACE Antibodies)aves the integral membrane form (show PMEL Antibodies) of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for (show BACE Antibodies) the formation of amyloid fibrils and downstream melanosome morphogenesis.
Inhibiting Chrna7 (show CHRNA7 Antibodies) expression markedly stimulated the production of Abeta (show APP Antibodies) through the mechanism of increased expression of BACE1 (show BACE Antibodies) and inhibited expression of BACE2 in SH-SY5Y cells.
BACE2 overexpression in cultured cells was found to lower net amyloid ss-protein levels.
The BACE2 distal promoter contains an activating cis (show CISH Antibodies)-regulatory element that is responsive to Trichostatin A (TSA (show PRDX2 Antibodies)) treatment according to promoter reporter assays in HEK (show EPHA3 Antibodies) 293 cells.
All these data point to a role for BACE2 in the IRbeta trafficking and insulin (show INS Antibodies) signaling. In conclusion, BACE2 is hereby presented as an important enzyme in beta-cell function.
the BACE1 (show BACE Antibodies) homologue BACE2 processes PMEL (show PMEL Antibodies) to generate functional amyloids. BACE2 is highly expressed in pigment cells and Bace2(-/-) but not Bace1 (show BACE Antibodies)(-/-) mice display coat color defects, implying a specific role for BACE2 during melanogenesis
non-redundant roles of BACE1 (show BACE Antibodies)/2 in ectodomain shedding with BACE1 (show BACE Antibodies) regulating a broader and BACE2 a more distinct set of beta-cell-enriched substrates including two proteins of the seizure 6 protein (show SEZ6L Antibodies) family (SEZ6L (show SEZ6L Antibodies) and SEZ6L2 (show SEZ6L2 Antibodies)).
Tmem27 (show TMEM27 Antibodies) dimerization is a dynamic process involving Bace2
Bace2 is a beta (show SUCLA2 Antibodies) cell-enriched protease that regulates pancreatic beta cell function and mass.
The TgBACE2-APP (show APP Antibodies) mice showed deregulation of BACE2 expression levels that were significantly increased with respect to single TgBACE2 mice.
Data show that BACE1 (show BACE Antibodies) knockout mice display a complex phenotype, and a combined deficiency of BACE2 and BACE1 (show BACE Antibodies) enhanced the bace1 (show BACE Antibodies)-/- lethality.
BACE1 (show BACE Antibodies) and BACE2 may act as alternative alpha-secretase-like proteases in proteolytic processing of IL-1R2 and APP (show APP Antibodies)
The presence of BACE2 in secretory granules of beta cells suggests that it may play a role in diabetes-associated amyloidogenesis.
Cerebral deposition of amyloid beta peptide is an early and critical feature of Alzheimer's disease and a frequent complication of Down syndrome. Amyloid beta peptide is generated by proteolytic cleavage of amyloid precursor protein by 2 proteases, one of which is the protein encoded by this gene. This gene localizes to the 'Down critical region' of chromosome 21. The encoded protein, a member of the peptidase A1 protein family, is a type I integral membrane glycoprotein and aspartic protease. Three transcript variants encoding different isoforms have been described for this gene.
56 kDa aspartic-like protease
, Down syndrome region aspartic protease
, aspartyl protease 1
, beta-secretase 2
, beta-site amyloid beta A4 precursor protein-cleaving enzyme 2
, membrane-associated aspartic protease 1
, transmembrane aspartic proteinase Asp1
, asp 1
, beta-site APP cleaving enzyme 2
, beta-site amyloid precursor protein cleaving enzyme 2